US Loses Another 3.8M Jobs Last week; Nearly 30M in 6 Weeks.

This morning the Department of Labor released the initial jobless claims data for the week ending April 25, the advance figure for seasonally adjusted initial claims was 3,839,000, another decline in data, however cumulatively we are now at over 30M claims over the last 6 weeks.


The four week moving average from jobless claims has now fallen to that of 5,033,250, a decrease of 757,000 from the previous week’s moving average. By comparison, the advance seasonally adjusted insured unemployment rate rose to 12.4% during the week ending April 18, a rise of 1.5% from the week prior. The data is reported with a one week delay relative to jobless claims.


Information for this briefing was found via the Department of Labor. The author has no securities or affiliations with any of the mentioned securities. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

2 Responses

Video Articles

Why the Market May Be Misreading Iran | David Woo

Why US Fertilizer Supply Could Matter a Lot More Now | Pat Varas – Sage Potash

Roscan Gold: Mali Discount Hits Kandiole PEA

Recommended

Canadian Gold Drills 19.5 g/t Gold Over 1.0 Metre At Lac Arsenault

Canadian Copper Secures Key Approval for Caribou Complex Acquisition

Related News

2020 Comes to an End With Nearly 20 Million Americans Still Collecting Unemployment Benefits

With the end of 2020 closing in, the number of initial jobless claims in the...

Saturday, January 2, 2021, 03:47:00 PM

Meat Processing Plants Turning to Robot Butchers to Reduce Coronavirus Infection Rates Among Workers

As the coronavirus pandemic continues to sweep across the US with record breaking infection rates,...

Sunday, July 12, 2020, 03:01:00 PM

Revive Files IND Application With FDA For Phase 3 Clinical Study For COVID-19 Treatment

Revive Therapeutics (CSE: RVV) announced after the bell today that it has officially filed its...

Tuesday, June 30, 2020, 07:18:46 PM

Revive Files Clinical Trial Application With Health Canada, Releases Phase 3 FDA Study Design For Potential Treatment Of COVID-19

Revive Therapeutics (CSE: RVV) continues to advance its clinical trial efforts. The company announced this...

Wednesday, June 3, 2020, 11:30:38 AM

Revive Expects To Complete Phase 3 Interim Analysis In December On Bucillamine In Treatment of COVID-19

Revive Therapeutics (CSE: RVV) provided an update on the status of its ongoing phase three...

Monday, October 26, 2020, 10:54:38 AM